Good morning, everyone, and how are you today? We hope the weekend was restful and invigorating. Now, of course, the routine has returned, along with a drenching rain here on the Pharmalot corporate campus. Nonetheless, our spirits remain sunny and you know why: 'Every brand new day should be unwrapped like a precious gift.' So please join us for a cup of stimulation as we sift through our to-do list. Hope your day goes well and stay in touch...
FDA Staff Endorses J&J And Bayer's Xarelto For Approval (Bloomberg News)
Senate Prepares To Vote On PDUFA (Wall Street Journal)
Which Biotechs Are On The Endangered Species List? (Xconomy)
Medical Group Demands India Ban 33 Drugs (Deecan Chronicle)
Pfizer Recalls 650,000 Bottles Of Advil Liqui-Gels (Fox Business)
AstraZeneca R&D Chief Forecasts Many Deals (Pharma Times)
J&J Successfully Sues Chinese Distributor For Breach (People's Daily)
Contract Sales Sector Shrunk In 2011: PDI (Outsourcing Pharma)
Ranbaxy Plans To Relaunch Skin Drug In The US (Economic Times)
Vaccine Trial Made Some Vulnerable To HIV (New York Times)
Glaxo To Co-Market Auxilium Testosterone Gel (Philadelphia Business Journal)
CDC Says Baby Boomers Should Be Tested For Hepatitis C (WebMD)
Is Generic Plavix Good For Patients Or Payers? (Family Practice News)
Momenta Is A 'Massachusetts Success' Story (Boston Globe)
EDITOR'S NOTE: Please check this post for updated items
rain pic thx to sterlic on flickr






4 Comments
NOTE - Perhaps their contract manufacturer did not get the "pallet memo" ... or found the replacement costs 'unpalatable' ... until now?
If I were the new CEO I would kick a** of this guy at my first day in office...
Coming from this biz, I can smell this as a marketing ploy a mile away.